Medeon Biodesign

Information

Medeon Biodesign (TPEx: 6499) is a publicly traded company that operates as an accelerator and venture capital firm focusing on biodesign and medical technology innovations. Entrepreneurs who partner with Medeon Biodesign can benefit from their extensive experience in the medical field, access to a vast network of industry professionals, and potential funding opportunities. Medeon Biodesign provides strategic guidance, technical support, and resources to help startups navigate the complexities of the healthcare market, from regulatory approvals to market entry strategies.

How to Apply

To apply for Medeon Biodesign's accelerator or investment opportunities, interested entrepreneurs should reach out via email at [email protected]. Applicants are encouraged to provide a comprehensive business plan, detailing their innovative medical technology, market potential, and strategic goals. The application process may involve multiple rounds of review and interviews to assess the viability and potential impact of the proposed technology.

Total number of startups invested: 2

Average Funding: Information not publicly available

Industry: Biodesign, Medical Technology, Healthcare Innovations

Market: Based in Taiwan, operates globally

Other Accelerators/VC/Investors

The Catalyst

The Catalyst is the region's first technology startup accelerator with a dedicated focus on sustainability and clean technology. In partnership with Masdar and BP, The Catalyst offers entrepreneurs ac...

View

AngelPad

AngelPad is a seed-stage accelerator program based in New York City and San Francisco. Founded in 2010, AngelPad has launched over 150 companies. Unlike other accelerators that focus on scaling, Angel...

View

Boomtown Accelerators

Innovation paves the way for positive transformation. We collaborate with clients worldwide to leverage the power of innovation across a variety of sectors, including health, education, sustainability...

View